Gimic Co

Gimic Co EBITDA Margin

The EBITDA Margin of Gimic Co (475A.T) as of Nov 4, 2026 is 8.33 %. In the previous year, EBITDA Margin was 5.49 % — a change of 51.64% (higher).

EBITDA Margin

8.33 %

YoY

51.64%

Last updated:

EBITDA Margin of Gimic Co is 2025 8.33 % . EBITDA Margin of Gimic Co was 2024 5.49 % . It decreases by 51.64% higher compared to the previous year.

The Gimic Co EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2024
5.49 JPY
Jan 1, 2025
8.33 JPY
The Gimic Co EBITDA Margin history
YEAREBITDA MarginYoY
8.33 %+51.64%
5.49 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Gimic Co Stock analysis

What does Gimic Co do? Gimic Co Ltd generates revenue through its medical specialized platform business, primarily leveraging Doctors File, a comprehensive patient-centric information platform. The company offers informational reports based on third-party interviews with doctors, enabling patients to select suitable healthcare providers without any recommendation-driven content. Additionally, Gimic provides the medical information magazine Tayoreru Doctor, the hospital-specific site Hospitals File, and the career support service Doctors File Agent for medical professionals. The company also monetizes its human resources management system Doctors File CLINICO, designed for clinic personnel evaluation and management. These products target patients seeking medical guidance, healthcare institutions requiring patient information services, and medical professionals needing career transition support. Gimic Co Ltd's revenue streams include subscriptions for access to Doctors File, sales of Tayoreru Doctor magazine, and licensing of Doctors File CLINICO to clinics. The company's primary customer segments are patients using the platform for doctor selection, hospitals utilizing Hospitals File for patient information, and medical professionals engaging with Doctors File Agent for career development. All services are delivered through digital platforms without physical retail presence, focusing on Japan's medical information market. The company's business model centers on providing objective, third-party medical information through multiple digital channels. Doctors File serves as the core product, while Tayoreru Doctor and Hospitals File extend its reach into broader medical information consumption. Doctors File Agent and Doctors File CLINICO cater to professional segments within the healthcare industry, creating a diversified revenue portfolio. All offerings are developed and operated within Japan, targeting domestic healthcare needs without international expansion. Gimic Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Gimic Co stock

EBITDA Margin of Gimic Co is 8.33 % in 2025.

EBITDA Margin of Gimic Co changed from 5.49 % to 8.33 %, representing a 51.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Gimic Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Gimic Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Gimic Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Gimic Co